{"id":4767,"date":"2021-12-16T15:30:00","date_gmt":"2021-12-16T14:30:00","guid":{"rendered":"https:\/\/leo-foundation.org\/en\/?p=4767"},"modified":"2022-05-17T10:15:48","modified_gmt":"2022-05-17T08:15:48","slug":"five-intriguing-skin-research-projects-to-be-awarded-dkk-16-5-million","status":"publish","type":"post","link":"https:\/\/leo-foundation.org\/en\/2021\/12\/16\/five-intriguing-skin-research-projects-to-be-awarded-dkk-16-5-million\/","title":{"rendered":"Five intriguing skin research projects to be awarded DKK 16.5 million"},"content":{"rendered":"\n
<\/div>\n\n\n\n

16 December 202<\/em>1<\/p>\n\n\n\n

\n
\n \n\n

Cutting-edge skin infection treatment that minimizes the risk of antibiotic resistance, important new insights into stem cell function, and a new diagnostic tool which may prevent the misdiagnosis of scleroderma; Just three out of five fundamental and exciting projects to be fueled by research grants from the LEO Foundation<\/strong><\/strong><\/p>\n\n\n\n

The LEO Foundation awards DKK 16.5 million to five researchers of excellence at the University of Copenhagen, Imperial College London, University Hospitals Cleveland Medical Center, Boston University School, and the University of London. The diverse group of grantees make up this year\u2019s third and final round of research grants from the Foundation \u2013 aiming at supporting research of the highest quality to discover more about the skin, its diseases and health, improving upon the lives of people living with skin diseases.<\/p>\n\n\n\n

The researchers pursue advances in both diagnosis and understanding of skin diseases, potentially offering insights capable of improving the quality of life of those affected. Per example, Professor Edel O\u2019Toole\u2019s project focuses on the genetic skin disease steatocystoma multiplex (SM), aiming to establish new insight into the rare and embarrassing condition \u2013 which causes many painful, smooth, and yellow cysts on the skin. The research offers potential contribution to the development of a new treatment for patients.<\/p>\n\n\n\n

Alternatively, Kevin Cooper\u2019s project tackles the inflammatory skin disease psoriasis, which causes red, itchy scaly patches on the skin. The research attempts to improve psoriasis treatment by better understanding the genetics of responders and non-responders to medication. The project therefore hopes to contribute to the development of a diagnostic test that may further facilitate improved treatment of the individual patient.<\/p>\n\n\n\n

Grantees and detailed descriptions of their research projects can be found below, where you can gain better understanding of their focus and impact upon the global scene of dermatological research.<\/p>\n\n\n<\/div>\n\n